BlackRock Institutional Trust’s Cytosorbents Corp CTSO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$246K Buy
2,258
+760
+51% +$83.2K ﹤0.01% 3566
2016
Q3
$192K Buy
1,498
+175
+13% +$18.2K ﹤0.01% 3611
2016
Q2
$120K Hold
1,323
– – ﹤0.01% 3681
2016
Q1
$104K Hold
1,323
– – ﹤0.01% 3711
2015
Q4
$147K Buy
1,323
+620
+88% +$84.4K ﹤0.01% 3697
2015
Q3
$89K Buy
703
+608
+640% +$81.1K ﹤0.01% 3743
2015
Q2
$12K Buy
+95
New +$12.9K ﹤0.01% 3867

Other funds holding CTSO

BlackRock Institutional Trust's CTSO Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Cytosorbents Corp (CTSO) stake by 51% in Q4 2016, buying an estimated $83.2K and bringing the position to 2,258 shares worth $246K. The position accounts for ﹤0.01% of the portfolio, ranked #3566.

BlackRock Institutional Trust first reported a position in CTSO in Q2 2015 and has held it in 7 quarters since. 38 funds tracked by Wall St. Rank hold CTSO as of Q4 2016.

  • BlackRock Institutional Trust held 2,258 shares of Cytosorbents Corp worth $246K as of Q4 2016.
  • BlackRock Institutional Trust bought 760 Cytosorbents Corp shares in Q4 2016, an estimated $83.2K.
  • Cytosorbents Corp made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3566 holding.
  • BlackRock Institutional Trust first reported a position in Cytosorbents Corp in Q2 2015 and has held it in 7 quarters since.
  • 38 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.